BEAT logo

HeartBeam, Inc. Stock Price

NasdaqCM:BEAT Community·US$56.6m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 5 Fair Values set on narratives written by author

BEAT Share Price Performance

US$1.65
-0.86 (-34.26%)
US$1.65
-0.86 (-34.26%)
Price US$1.65

BEAT Community Narratives

There are no narratives available yet.

Snowflake Analysis

Medium-low risk with adequate balance sheet.

7 Risks
1 Reward

HeartBeam, Inc. Key Details

US$0

Revenue

US$0

Cost of Revenue

US$0

Gross Profit

US$20.3m

Other Expenses

-US$20.3m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Nov 13, 2025
-0.59
0%
0%
0%
View Full Analysis

About BEAT

Founded
2015
Employees
19
CEO
Robert Eno
WebsiteView website
www.heartbeam.com

HeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing ambulatory electrocardiogram solutions that enable the detection and monitoring of cardiac disease inside and outside a healthcare facility setting. The company develops three-dimensional vector images of cardiac electrical activity. It is developing HeartBeam AIMIGo, a credit card-sized cloud-based diagnostic software systems to address heart attack detection. The company was incorporated in 2015 and is based in Santa Clara, California.

Recent BEAT News & Updates

Recent updates

No updates